Aghdaki, Maryam
Stromal Cell-Derived Factor1 Genetic Variation at Locus 801 in Patients with Endometrial Cancer [Volume 16, Issue 2, 2025, Pages 181-188]
Ağyol, Yeşim
Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients [Volume 16, Issue 2, 2025, Pages 162-169]
Ahmadi, Amirhossein
Anticancer Activity of Holothuria Leucospilota-Derived Saponin on MKN45 Gastric Cancer Cell via Upregulation of CDH1 Hub Gene [Volume 16, Issue 1, 2025, Pages 24-38]
Alborzi, Saeed
Endometriosis-associated Ovarian Cancer, from Risk Factors to Survival Rate: A Systematic Review and Meta-Analysis [Volume 16, Issue 1, 2025, Pages 1-23]
Alnemr, Mohamed Abdelmohsen
Clinical Benefits of Metronomic Chemotherapy in Platinum-Refractory, Recurrent, and Metastatic Head and Neck Squamous Cell Carcinoma [Volume 16, Issue 1, 2025, Pages 99-107]
Anvari, Kazem
Pediatric Pituitary Pituicytoma: A Case Report of Comprehensive Management [Volume 16, Issue 2, 2025, Pages 189-195]
Arafat, Yaser
The Effect of Proton Pump Inhibitors on Metastatic Breast Cancer in Patients Treated with CDK4/6i [Volume 16, Issue 2, 2025, Pages 170-180]
Arıkan, Rukiye
Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients [Volume 16, Issue 2, 2025, Pages 162-169]
Arumugam, Paramasivam
Deciphering the Genetic Alterations in PIK3CA Gene Interacting Network and Their Putative Association with Breast Cancer: A Computational Approach [Volume 16, Issue 1, 2025, Pages 49-58]
Arumugam, Paramasivam
High Expression of Myosin ⅩⅥ Predicts Poor Prognosis in Head and Neck Squamous Cell Carcinoma [Volume 16, Issue 2, 2025, Pages 118-126]
Asadi, Milad
Aberrant DNA Methylation of FTH-1 and SHOX2 Contributes to Lung Cancer Progression [Volume 16, Issue 1, 2025, Pages 59-67]
Asadi, Milad
Exploring miR-30b Methylation and MALAT-1 Expression as Diagnostic Biomarkers for Non-Small Cell Lung Cancer [Volume 16, Issue 2, 2025, Pages 127-138]
Asadzadeh, Azizeh
Identification of Breast Cancer Biomarkers by Constructing Protein-Protein Interaction and miRNAs-mRNAs Networks [Volume 16, Issue 1, 2025, Pages 39-48]
Askary, Elham
Endometriosis-associated Ovarian Cancer, from Risk Factors to Survival Rate: A Systematic Review and Meta-Analysis [Volume 16, Issue 1, 2025, Pages 1-23]
Awadallah, Mohamed
The Effect of Proton Pump Inhibitors on Metastatic Breast Cancer in Patients Treated with CDK4/6i [Volume 16, Issue 2, 2025, Pages 170-180]
Ayatollahi, Amirali
Lysophosphatidylcholine Acyltransferase 1 (LPCAT1): A Predictor of Acute Leukemia Prognosis [Volume 16, Issue 1, 2025, Pages 90-98]
Ayatollahi, Hossein
Lysophosphatidylcholine Acyltransferase 1 (LPCAT1): A Predictor of Acute Leukemia Prognosis [Volume 16, Issue 1, 2025, Pages 90-98]
B
Bai, Lin
N-Nornuciferine Promotes Human Non-Small Cell Lung Cancer A549 Cells Apoptosis via miR-361-3p/TRAF2/JNK Axis [Volume 16, Issue 2, 2025, Pages 139-149]
Bakry, Adel
Clinical Benefits of Metronomic Chemotherapy in Platinum-Refractory, Recurrent, and Metastatic Head and Neck Squamous Cell Carcinoma [Volume 16, Issue 1, 2025, Pages 99-107]
Bayoğlu, İbrahim Vedat
Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients [Volume 16, Issue 2, 2025, Pages 162-169]
Behboodian, Bita
Identification of Breast Cancer Biomarkers by Constructing Protein-Protein Interaction and miRNAs-mRNAs Networks [Volume 16, Issue 1, 2025, Pages 39-48]
Beheshti Namdar, Ali
MLH1 Methylation-Based Testing in Peripheral Blood Mononuclear Cells is a Promising Biomarker for Colorectal Cancer Diagnosis and Prognosis [Volume 16, Issue 2, 2025, Pages 109-117]
Bernoos, Parsa
Identification of Breast Cancer Biomarkers by Constructing Protein-Protein Interaction and miRNAs-mRNAs Networks [Volume 16, Issue 1, 2025, Pages 39-48]
Boroumand-Noughabi, Samaneh
Lysophosphatidylcholine Acyltransferase 1 (LPCAT1): A Predictor of Acute Leukemia Prognosis [Volume 16, Issue 1, 2025, Pages 90-98]
C
Chamanara, Kefayat
Endometriosis-associated Ovarian Cancer, from Risk Factors to Survival Rate: A Systematic Review and Meta-Analysis [Volume 16, Issue 1, 2025, Pages 1-23]
D
Dayakar, Sivapriya
Deciphering the Genetic Alterations in PIK3CA Gene Interacting Network and Their Putative Association with Breast Cancer: A Computational Approach [Volume 16, Issue 1, 2025, Pages 49-58]
E
Eesa, Mohamed
Clinical Benefits of Metronomic Chemotherapy in Platinum-Refractory, Recurrent, and Metastatic Head and Neck Squamous Cell Carcinoma [Volume 16, Issue 1, 2025, Pages 99-107]
Elshafaay, Basant SH.
The Effect of Proton Pump Inhibitors on Metastatic Breast Cancer in Patients Treated with CDK4/6i [Volume 16, Issue 2, 2025, Pages 170-180]
Elwan, Amira
Clinical Benefits of Metronomic Chemotherapy in Platinum-Refractory, Recurrent, and Metastatic Head and Neck Squamous Cell Carcinoma [Volume 16, Issue 1, 2025, Pages 99-107]
Ercelep, Özlem
Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients [Volume 16, Issue 2, 2025, Pages 162-169]
Erel, Pınar
Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients [Volume 16, Issue 2, 2025, Pages 162-169]
F
Fan, Jiawei
Positive Expression of IGFBP2 as a Novel Prognostic Biomarker for Patients with Lower-Grade Gliomas [Volume 16, Issue 1, 2025, Pages 79-89]
Fattahi, Mohammad Javad
Stromal Cell-Derived Factor1 Genetic Variation at Locus 801 in Patients with Endometrial Cancer [Volume 16, Issue 2, 2025, Pages 181-188]
G
Ghasemi, Ahmad
Anticancer Activity of Holothuria Leucospilota-Derived Saponin on MKN45 Gastric Cancer Cell via Upregulation of CDH1 Hub Gene [Volume 16, Issue 1, 2025, Pages 24-38]
Güren, Ali Kaan
Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients [Volume 16, Issue 2, 2025, Pages 162-169]
H
Haghshenas, Mohammad Reza
Stromal Cell-Derived Factor1 Genetic Variation at Locus 801 in Patients with Endometrial Cancer [Volume 16, Issue 2, 2025, Pages 181-188]
Han, Fang
Positive Expression of IGFBP2 as a Novel Prognostic Biomarker for Patients with Lower-Grade Gliomas [Volume 16, Issue 1, 2025, Pages 79-89]
Hanna, Amira
The Effect of Proton Pump Inhibitors on Metastatic Breast Cancer in Patients Treated with CDK4/6i [Volume 16, Issue 2, 2025, Pages 170-180]
Hashemian, Hamidreza
Pediatric Pituitary Pituicytoma: A Case Report of Comprehensive Management [Volume 16, Issue 2, 2025, Pages 189-195]
Hashemzadeh, Shahryar
Aberrant DNA Methylation of FTH-1 and SHOX2 Contributes to Lung Cancer Progression [Volume 16, Issue 1, 2025, Pages 59-67]
Hashemzadeh, Shahryar
Exploring miR-30b Methylation and MALAT-1 Expression as Diagnostic Biomarkers for Non-Small Cell Lung Cancer [Volume 16, Issue 2, 2025, Pages 127-138]
Heidary Sadegh, Mahshid
Cytogenetics and Molecular Abnormalities in Pediatric Patients with Acute Myeloid Leukemia in a Referral Center in Tehran, Iran [Volume 16, Issue 1, 2025, Pages 68-78]
Hosseini, Marzieh
Cytogenetics and Molecular Abnormalities in Pediatric Patients with Acute Myeloid Leukemia in a Referral Center in Tehran, Iran [Volume 16, Issue 1, 2025, Pages 68-78]
I
Işık, Selver
Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients [Volume 16, Issue 2, 2025, Pages 162-169]
Ismail, Hoda
Clinical Benefits of Metronomic Chemotherapy in Platinum-Refractory, Recurrent, and Metastatic Head and Neck Squamous Cell Carcinoma [Volume 16, Issue 1, 2025, Pages 99-107]
Izanloo, Elham
Stromal Cell-Derived Factor1 Genetic Variation at Locus 801 in Patients with Endometrial Cancer [Volume 16, Issue 2, 2025, Pages 181-188]
J
Jayaseelan, Vijayashree Priyadharsini
High Expression of Myosin ⅩⅥ Predicts Poor Prognosis in Head and Neck Squamous Cell Carcinoma [Volume 16, Issue 2, 2025, Pages 118-126]
Jayaseelan, Vijayashree Priyadharsini
Deciphering the Genetic Alterations in PIK3CA Gene Interacting Network and Their Putative Association with Breast Cancer: A Computational Approach [Volume 16, Issue 1, 2025, Pages 49-58]
K
Kannan, Balachander
High Expression of Myosin ⅩⅥ Predicts Poor Prognosis in Head and Neck Squamous Cell Carcinoma [Volume 16, Issue 2, 2025, Pages 118-126]
Keramati, Mohammad Reza
Lysophosphatidylcholine Acyltransferase 1 (LPCAT1): A Predictor of Acute Leukemia Prognosis [Volume 16, Issue 1, 2025, Pages 90-98]
Keshtvarz Hesam Abadi, Alimohammad
Endometriosis-associated Ovarian Cancer, from Risk Factors to Survival Rate: A Systematic Review and Meta-Analysis [Volume 16, Issue 1, 2025, Pages 1-23]
Khajavi, Maryam
Lysophosphatidylcholine Acyltransferase 1 (LPCAT1): A Predictor of Acute Leukemia Prognosis [Volume 16, Issue 1, 2025, Pages 90-98]
Khalifa, Mohamed
The Effect of Proton Pump Inhibitors on Metastatic Breast Cancer in Patients Treated with CDK4/6i [Volume 16, Issue 2, 2025, Pages 170-180]
Khansalar, Soolmaz
Stromal Cell-Derived Factor1 Genetic Variation at Locus 801 in Patients with Endometrial Cancer [Volume 16, Issue 2, 2025, Pages 181-188]
Kocaaslan, Erkam
Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients [Volume 16, Issue 2, 2025, Pages 162-169]
Köstek, Osman
Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients [Volume 16, Issue 2, 2025, Pages 162-169]
L
Li, Wenfei
Positive Expression of IGFBP2 as a Novel Prognostic Biomarker for Patients with Lower-Grade Gliomas [Volume 16, Issue 1, 2025, Pages 79-89]
Li, Yanguo
Positive Expression of IGFBP2 as a Novel Prognostic Biomarker for Patients with Lower-Grade Gliomas [Volume 16, Issue 1, 2025, Pages 79-89]
M
Mahgoub, Isra
The Effect of Proton Pump Inhibitors on Metastatic Breast Cancer in Patients Treated with CDK4/6i [Volume 16, Issue 2, 2025, Pages 170-180]
Majidova, Nargiz
Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients [Volume 16, Issue 2, 2025, Pages 162-169]
Mazhari, Arefeh
Lysophosphatidylcholine Acyltransferase 1 (LPCAT1): A Predictor of Acute Leukemia Prognosis [Volume 16, Issue 1, 2025, Pages 90-98]
Mehrad-Majd, Hassan
MLH1 Methylation-Based Testing in Peripheral Blood Mononuclear Cells is a Promising Biomarker for Colorectal Cancer Diagnosis and Prognosis [Volume 16, Issue 2, 2025, Pages 109-117]
Memarzadeh, Marziyeh
Exploring miR-30b Methylation and MALAT-1 Expression as Diagnostic Biomarkers for Non-Small Cell Lung Cancer [Volume 16, Issue 2, 2025, Pages 127-138]
Mohamed, Yara
The Effect of Proton Pump Inhibitors on Metastatic Breast Cancer in Patients Treated with CDK4/6i [Volume 16, Issue 2, 2025, Pages 170-180]
Mohammed, Amrallah
The Effect of Proton Pump Inhibitors on Metastatic Breast Cancer in Patients Treated with CDK4/6i [Volume 16, Issue 2, 2025, Pages 170-180]
Mosallaei, Meysam
MLH1 Methylation-Based Testing in Peripheral Blood Mononuclear Cells is a Promising Biomarker for Colorectal Cancer Diagnosis and Prognosis [Volume 16, Issue 2, 2025, Pages 109-117]
Movahedinia, Sajjadeh
Cytogenetics and Molecular Abnormalities in Pediatric Patients with Acute Myeloid Leukemia in a Referral Center in Tehran, Iran [Volume 16, Issue 1, 2025, Pages 68-78]
Mozafari, Maniya
Cytogenetics and Molecular Abnormalities in Pediatric Patients with Acute Myeloid Leukemia in a Referral Center in Tehran, Iran [Volume 16, Issue 1, 2025, Pages 68-78]
N
Najib, Fateme Sadat
Stromal Cell-Derived Factor1 Genetic Variation at Locus 801 in Patients with Endometrial Cancer [Volume 16, Issue 2, 2025, Pages 181-188]
Obaya, Ahmed
The Effect of Proton Pump Inhibitors on Metastatic Breast Cancer in Patients Treated with CDK4/6i [Volume 16, Issue 2, 2025, Pages 170-180]
Oveisi, Zahra
Stromal Cell-Derived Factor1 Genetic Variation at Locus 801 in Patients with Endometrial Cancer [Volume 16, Issue 2, 2025, Pages 181-188]
P
Pandi, Anitha
Deciphering the Genetic Alterations in PIK3CA Gene Interacting Network and Their Putative Association with Breast Cancer: A Computational Approach [Volume 16, Issue 1, 2025, Pages 49-58]
Pandi, Anitha
High Expression of Myosin ⅩⅥ Predicts Poor Prognosis in Head and Neck Squamous Cell Carcinoma [Volume 16, Issue 2, 2025, Pages 118-126]
Pandi, Chandra
Deciphering the Genetic Alterations in PIK3CA Gene Interacting Network and Their Putative Association with Breast Cancer: A Computational Approach [Volume 16, Issue 1, 2025, Pages 49-58]
Pandi, Chandra
High Expression of Myosin ⅩⅥ Predicts Poor Prognosis in Head and Neck Squamous Cell Carcinoma [Volume 16, Issue 2, 2025, Pages 118-126]
Prajoko, Yan Wisnu
Ozonated Aloe Vera Oil Accelerates Radiation Dermatitis Healing in Sprague Dawley Rats [Volume 16, Issue 2, 2025, Pages 150-161]
R
Raeisi, Mortaza
Aberrant DNA Methylation of FTH-1 and SHOX2 Contributes to Lung Cancer Progression [Volume 16, Issue 1, 2025, Pages 59-67]
Raeisi, Mortaza
Exploring miR-30b Methylation and MALAT-1 Expression as Diagnostic Biomarkers for Non-Small Cell Lung Cancer [Volume 16, Issue 2, 2025, Pages 127-138]
Ramasubramanian, Abilasha
High Expression of Myosin ⅩⅥ Predicts Poor Prognosis in Head and Neck Squamous Cell Carcinoma [Volume 16, Issue 2, 2025, Pages 118-126]
S
Sabbagh-Jadid, Hamed
Aberrant DNA Methylation of FTH-1 and SHOX2 Contributes to Lung Cancer Progression [Volume 16, Issue 1, 2025, Pages 59-67]
Sabbagh-Jadid, Hamed
Exploring miR-30b Methylation and MALAT-1 Expression as Diagnostic Biomarkers for Non-Small Cell Lung Cancer [Volume 16, Issue 2, 2025, Pages 127-138]
Sadegh, Khadijeh
Anticancer Activity of Holothuria Leucospilota-Derived Saponin on MKN45 Gastric Cancer Cell via Upregulation of CDH1 Hub Gene [Volume 16, Issue 1, 2025, Pages 24-38]
Sadeghi, Armin
Aberrant DNA Methylation of FTH-1 and SHOX2 Contributes to Lung Cancer Progression [Volume 16, Issue 1, 2025, Pages 59-67]
Sadeghi, Armin
Exploring miR-30b Methylation and MALAT-1 Expression as Diagnostic Biomarkers for Non-Small Cell Lung Cancer [Volume 16, Issue 2, 2025, Pages 127-138]
Sadeghi, Shahryar
MLH1 Methylation-Based Testing in Peripheral Blood Mononuclear Cells is a Promising Biomarker for Colorectal Cancer Diagnosis and Prognosis [Volume 16, Issue 2, 2025, Pages 109-117]
Safavi, Moeinadin
Cytogenetics and Molecular Abnormalities in Pediatric Patients with Acute Myeloid Leukemia in a Referral Center in Tehran, Iran [Volume 16, Issue 1, 2025, Pages 68-78]
Saleki, Noushin
Pediatric Pituitary Pituicytoma: A Case Report of Comprehensive Management [Volume 16, Issue 2, 2025, Pages 189-195]
Sarı, Murat
Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients [Volume 16, Issue 2, 2025, Pages 162-169]
Sever, Nadiye
Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients [Volume 16, Issue 2, 2025, Pages 162-169]
Shadi, Ahmad
Anticancer Activity of Holothuria Leucospilota-Derived Saponin on MKN45 Gastric Cancer Cell via Upregulation of CDH1 Hub Gene [Volume 16, Issue 1, 2025, Pages 24-38]
Sheikhi, Maryam
Lysophosphatidylcholine Acyltransferase 1 (LPCAT1): A Predictor of Acute Leukemia Prognosis [Volume 16, Issue 1, 2025, Pages 90-98]
Shen, Zhuo
Positive Expression of IGFBP2 as a Novel Prognostic Biomarker for Patients with Lower-Grade Gliomas [Volume 16, Issue 1, 2025, Pages 79-89]
Shojaei Barjouei, Masoumeh
Identification of Breast Cancer Biomarkers by Constructing Protein-Protein Interaction and miRNAs-mRNAs Networks [Volume 16, Issue 1, 2025, Pages 39-48]
Siyadat, Payam
Lysophosphatidylcholine Acyltransferase 1 (LPCAT1): A Predictor of Acute Leukemia Prognosis [Volume 16, Issue 1, 2025, Pages 90-98]
Suryadevara, Keerti Pranith
High Expression of Myosin ⅩⅥ Predicts Poor Prognosis in Head and Neck Squamous Cell Carcinoma [Volume 16, Issue 2, 2025, Pages 118-126]
T
Tahmasbi, Salar
Aberrant DNA Methylation of FTH-1 and SHOX2 Contributes to Lung Cancer Progression [Volume 16, Issue 1, 2025, Pages 59-67]
V
Vasei, Mohammad
Cytogenetics and Molecular Abnormalities in Pediatric Patients with Acute Myeloid Leukemia in a Referral Center in Tehran, Iran [Volume 16, Issue 1, 2025, Pages 68-78]
W
Wang, Chengxiang
N-Nornuciferine Promotes Human Non-Small Cell Lung Cancer A549 Cells Apoptosis via miR-361-3p/TRAF2/JNK Axis [Volume 16, Issue 2, 2025, Pages 139-149]
Y
Yin, Xuemei
Positive Expression of IGFBP2 as a Novel Prognostic Biomarker for Patients with Lower-Grade Gliomas [Volume 16, Issue 1, 2025, Pages 79-89]
Yousefisadr, Farzaneh
MLH1 Methylation-Based Testing in Peripheral Blood Mononuclear Cells is a Promising Biomarker for Colorectal Cancer Diagnosis and Prognosis [Volume 16, Issue 2, 2025, Pages 109-117]
Z
Zafari, Venus
Aberrant DNA Methylation of FTH-1 and SHOX2 Contributes to Lung Cancer Progression [Volume 16, Issue 1, 2025, Pages 59-67]
Zafari, Venus
Exploring miR-30b Methylation and MALAT-1 Expression as Diagnostic Biomarkers for Non-Small Cell Lung Cancer [Volume 16, Issue 2, 2025, Pages 127-138]
Zarredar, Habib
Aberrant DNA Methylation of FTH-1 and SHOX2 Contributes to Lung Cancer Progression [Volume 16, Issue 1, 2025, Pages 59-67]
Zarredar, Habib
Exploring miR-30b Methylation and MALAT-1 Expression as Diagnostic Biomarkers for Non-Small Cell Lung Cancer [Volume 16, Issue 2, 2025, Pages 127-138]
Zhang, Jun
Positive Expression of IGFBP2 as a Novel Prognostic Biomarker for Patients with Lower-Grade Gliomas [Volume 16, Issue 1, 2025, Pages 79-89]